PBZ-SR Overview


TRIPELENNAMINE HYDROCHLORIDE

  • TABLET, EXTENDED RELEASE; ORAL: 50MG

Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).

FDA applicationDosage FormStrengthMarketing StatusCompany
NDA #010533TABLET, EXTENDED RELEASE; ORAL50MGDiscontinuedNOVARTIS
Click on a application number to view drug details